DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/c8phkl/global_psoriasis) has announced the addition of the "Global Psoriasis Pipeline Capsule - 2013" report to their offering.

Fore Pharma's latest report Global Psoriasis Pipeline Capsule - 2013' provides up-to-date information on key Research and Development (R&D) activities in the global psoriasis market. It covers active psoriasis pipeline molecules in clinical trials, preclinical research, and drug discovery.

This report helps executives track competitor pipeline molecules. The pipeline data presented in this report can be used for identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

The scope of the report includes information on psoriasis pipeline molecules by clinical trial stages, company, mechanism of action, and country (The US, Germany, France, Italy, Spain, UK, Japan, and Rest of the World). Psoriasis pipeline molecules licensing activities are also covered in this report.

Key Features of the Report:

- Psoriasis Pipeline Overview

- Psoriasis Phase 3 Clinical Trial Pipeline

- Psoriasis Phase 2 Clinical Trial Pipeline

- Psoriasis Phase 1 Clinical Trial Pipeline

See original here:

Research and Markets: Global Psoriasis Pipeline Capsule - 2013 Report Available now for Review